To determine the chronic effects of COVID-19 drugs FLV and LPV on cardiac hERG potassium channels, we performed long-term incubations of these drugs with HEK-293 cells stably expressing hERG and human-induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs). The gene discussed is KCNH2; the disease is COVID-19.